A model to detect interactions between roxithromycin and oral contraceptives.

Area of Science:

• Pharmacology
• Reproductive Health
• Microbiology

Background:

• Oral contraceptives (OCs) are widely used for pregnancy prevention.
• Interactions between antibiotics and OCs can potentially reduce contraceptive efficacy.
• Roxithromycin is a newer macrolide antibiotic agent.

Purpose of the Study:

• To investigate potential interactions between roxithromycin and triphasic oral contraceptives.
• To determine if roxithromycin affects the ovulation-suppressing activity of triphasic OCs.

Main Methods:

• A four-cycle study involving 22 healthy women.
• Ovulation was monitored via serum progesterone levels and ovarian sonography.
• Participants took triphasic OCs alone, with roxithromycin, or with rifampin.

Main Results:

• No ovulation occurred when women took triphasic OCs alone or with roxithromycin.
• Rifampin, however, led to ovulation in 11 women taking OCs.
• Roxithromycin did not compromise the ovulation-inhibiting effect of the OCs.

Conclusions:

• Roxithromycin does not appear to interfere with the efficacy of triphasic oral contraceptives.
• Rifampin demonstrated a significant interaction, reducing OC efficacy.
• Clinical monitoring for OC efficacy is crucial when co-administering with certain antibiotics like rifampin.